A single oral dose of diflucan was administered to 37 patients during
exacerbation of chronic candidal vulvovaginitis. Complete clinicomycol
ogic cure was attained in 30 (81 %) patients 7 days and in 25 (68 %) o
nes 30 days after the drug intake. Hence, diflucan (fluconasole) is a
highly effective drug for the treatment of candidal vulvovaginitis, no
ntoxic, and causing no side effects.